1. Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia
- Author
-
Jeffrey V. Ravetch, William A. Frazier, Mattias Olsson, Per-Arne Oldenborg, Pierre Bruhns, Umeå University, Rockefeller University [New York], Washington University School of Medicine in St. Louis, and Washington University in Saint Louis (WUSTL)
- Subjects
MESH: Signal Transduction ,MESH: Membrane Glycoproteins ,Hemostasis, Thrombosis, and Vascular Biology ,Biochemistry ,MESH: Mice, Knockout ,MESH: Genotype ,Mice ,0302 clinical medicine ,Homeostasis ,Macrophage ,Platelet ,MESH: Animals ,Receptors, Immunologic ,MESH: Phagocytosis ,MESH: Antigens, CD ,Cellular Senescence ,MESH: Blood Platelets ,Mice, Knockout ,0303 health sciences ,Membrane Glycoproteins ,MESH: Purpura, Thrombocytopenic, Idiopathic ,Hematology ,3. Good health ,MESH: Homeostasis ,030220 oncology & carcinogenesis ,MESH: Antigens, Differentiation ,[SDV.IMM]Life Sciences [q-bio]/Immunology ,Cell aging ,Signal Transduction ,Blood Platelets ,medicine.medical_specialty ,Genotype ,Phagocytosis ,Immunology ,CD47 Antigen ,Neural Cell Adhesion Molecule L1 ,Platelet Transfusion ,Biology ,03 medical and health sciences ,Antigens, CD ,Internal medicine ,medicine ,Signal-regulatory protein alpha ,MESH: Platelet Transfusion ,Animals ,Opsonin ,MESH: Receptors, Immunologic ,MESH: Mice ,030304 developmental biology ,Purpura, Thrombocytopenic, Idiopathic ,CD47 ,MESH: CD47 Antigen ,MESH: Neural Cell Adhesion Molecule L1 ,MESH: Cellular Senescence ,Cell Biology ,Antigens, Differentiation ,Platelet transfusion ,Endocrinology - Abstract
Interaction between target cell CD47 and the inhibitory macrophage receptor signal regulatory protein α (SIRPα) counteracts macrophage phagocytosis of CD47-expressing host cells. As platelets also express CD47, we asked whether inhibitory CD47/SIRPα signaling regulates normal platelet turnover and clearance of platelets in immune thrombocytopenic purpura (ITP). CD47-/- mice had a mild spontaneous thrombocytopenia, which was not due to a decreased platelet half-life as a result of increased expression of P-selectin, CD61, or phosphatidylserine. In contrast, CD47-/- platelets were rapidly cleared when transfused into CD47+/+ recipients, whereas CD47+/- platelets had a nearly normal half-life in CD47+/+ mice under nonautoimmune conditions. CD47-/- mice were more sensitive to ITP, as compared with CD47+/+ mice. In vitro, macrophage phagocytosis of immunoglobulin G (IgG)–opsonized CD47-/- platelets was significantly higher than that for equally opsonized CD47+/+ platelets. However, when SIRPα was blocked, phagocytosis of CD47+/+ platelets increased to the level of CD47-/- platelets. Phagocytosis of opsonized CD47+/- platelets was higher than that for CD47+/+ platelets, but lower than that for CD47-/- platelets, suggesting a gene-dose effect of CD47 in this system. In conclusion, we suggest that inhibitory CD47/SIRPα signaling is involved in regulating platelet phagocytosis in ITP, and that targeting SIRPα may be a new means of reducing platelet clearance in ITP.
- Published
- 2005
- Full Text
- View/download PDF